INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

79 studies · page 2 of 4

2020 / Cohort study and meta-analysis of prospective cohort studies

Pooled prospective studies found no significant association between potato consumption and total, cardiovascular, or stroke mortality.

In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).

Shows an association, not proof of cause and effect.

Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135

2020 / Systematic review and meta-analysis

Premature graying of hair was associated with smoking, vitamin deficiencies, mineral deficiencies, and coronary artery disease.

A systematic review and meta-analysis evaluated risk factors, comorbidities, pharmacotherapy, and reversal of premature graying of hair (PGH). Smoking, vitamin deficiencies (B12, folic acid, and B7), and mineral deficiencies (low serum calcium and serum ferritin) were found to be associated with PGH. Other associated factors included obesity, high blood pressure, lack of exercise, and CAD. Low-grade recommendation (2A) was given to calcium pantothenate, PABA, and their combination, and treating accompanying pathologies led to disease reversal in many cases.

Shows an association, not proof of cause and effect.

Mahendiratta S, Sarma P, Kaur H, et al. Dermatol Ther, 2020. PMID 32654282

2020 / Systematic review and meta-analysis of administrative cohort studies

Bariatric surgery was linked to reduced all-cause mortality and lower incidence of T2DM, hypertension, and heart disease at the population level.

A systematic review and meta-analysis of 18 administrative database cohort studies evaluated 1,539,904 individuals (269,818 undergoing bariatric surgery and 1,270,086 controls) with at least 18 months of follow-up. Bariatric surgery was associated with reduced all-cause mortality (POR 0.62, 95% CI 0.55 to 0.69, p < 0.001) and cardiovascular mortality (POR 0.50, 95% CI 0.35 to 0.71, p < 0.001). It was also linked to reduced incidence of T2DM (POR 0.39), hypertension (POR 0.36), dyslipidaemia (POR 0.33), and ischemic heart disease (POR 0.46). Key limitations include inability to account for unmeasured variables due to non-randomised designs, heterogeneity in control groups, and lack of data on potential adverse surgical outcomes.

Shows an association, not proof of cause and effect.

Wiggins T, Guidozzi N, Welbourn R, et al. PLoS Med, 2020. PMID 32722673

2020 / Systematic review and meta-analysis of randomized controlled trials

Taurine supplementation significantly reduced systolic and diastolic blood pressure, total cholesterol, and triglycerides in randomized controlled trials.

A meta-analysis of 12 randomized controlled trials evaluated the effects of taurine supplementation (0.5 to 6 g/d for 15 days to 6 months), primarily in patients with liver or metabolic dysregulation. Taurine significantly reduced systolic blood pressure (WMD: -4.67 mm Hg; 95% CI, -9.10 to -0.25), diastolic blood pressure (WMD: -2.90 mm Hg; 95% CI, -4.29 to -1.52), total cholesterol (WMD: -10.87 mg/dl; 95% CI, -16.96 to -4.79), and triglycerides (WMD: -13.05 mg/dl; 95% CI, -25.88 to -0.22). It had no significant effect on fasting blood glucose (WMD: 0.06 mg/dl), HDL-C (WMD: 0.90 mg/dl), LDL-C (WMD: -6.17 mg/dl), body mass index (WMD: -0.46 kg/m2), or body weight (WMD: -0.47 kg).

Guan L, Miao P Eur J Pharmacol, 2020. PMID 32871172

2019 / Systematic review and meta-analysis of observational studies

French fries intake was linked to higher risk of diabetes and hypertension.

Researchers analyzed 28 reports examining potato intake and chronic disease risks. Total potato consumption showed no associations with all-cause mortality (RR 0.88, 95% CI 0.69-1.12), coronary heart disease, stroke, or colorectal cancer per 150 g/day increase. Conversely, each 150 g/day increase in French fries intake was linked to higher risks of type 2 diabetes (RR 1.66, 95% CI 1.43-1.94) and hypertension (RR 1.37, 95% CI 1.15-1.63), based on mostly low- to moderate-certainty evidence.

Shows an association, not proof of cause and effect.

Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Eur J Nutr, 2019. PMID 29987352

2019 / Systematic reviews and meta-analyses of prospective cohorts and trials

Higher intake of dietary fiber was linked to lower mortality and disease incidence, and reduced bodyweight and blood pressure in trials.

Researchers analyzed 185 prospective studies and 58 clinical trials examining carbohydrate quality markers. Observational data suggested a 15-30% decrease in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing highest versus lowest dietary fiber consumers. Clinical trials showed significantly lower bodyweight, systolic blood pressure, and total cholesterol with higher dietary fiber intakes. Similar findings were observed for whole grains, whereas evidence for low glycemic index or load showed smaller or no risk reductions.

Reynolds A, Mann J, Cummings J, et al. Lancet, 2019. PMID 30638909

2018 / Meta-analysis of randomized controlled trials

Chlorella supplementation reduces blood pressure, cholesterol, and fasting glucose in randomized trials

A meta-analysis of 19 randomized controlled trials with 797 subjects assessed Chlorella supplementation on cardiovascular risk markers. Chlorella significantly reduced total cholesterol by -9.09 mg/dL (95% CI -12.91 to -5.26), LDL cholesterol by -8.32 mg/dL (95% CI -12.22 to -4.42), systolic blood pressure by -4.51 mmHg (95% CI -6.53 to -2.48), diastolic blood pressure by -1.64 mmHg (95% CI -3.28 to -0.01), and fasting blood glucose by -4.23 mg/dL (95% CI -8.29 to -0.17). Triglycerides, HDL cholesterol, and BMI did not change significantly.

Fallah AA, Sarmast E, Habibian Dehkordi S, et al. Clin Nutr, 2018. PMID 29037431

2018 / Systematic review and meta-analysis of clinical trials

Licorice consumption reduced body weight and BMI but significantly increased diastolic blood pressure in a meta-analysis of clinical trials.

A systematic review and meta-analysis of 26 clinical trials with 985 patients evaluated metabolic changes following licorice consumption. Licorice significantly reduced body weight (WMD: -0.433 kg; 95% CI: -0.683 to -0.183; p = 0.001) and BMI (WMD: -0.150 kg/m2; 95% CI: -0.241 to -0.058; p = 0.001). However, it also significantly increased diastolic blood pressure (1.737 mmHg; 95% CI: 0.835 to 2.621; p < 0.0001), which is related to hypernatremia caused by licorice.

Luís Â, Domingues F, Pereira L Phytomedicine, 2018. PMID 29433679

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2018 / Systematic review of intervention studies

A systematic review suggests 160 minutes of weekly aerobic exercise for 6 months helps reduce erectile dysfunction related to cardiovascular risk factors.

A systematic review following PRISMA guidelines examined intervention studies published from 2006 through 2016 investigating physical activity as a treatment for erectile dysfunction (ED). Ten articles met inclusion criteria. The authors concluded that supervised aerobic exercise of moderate-to-vigorous intensity for 40 minutes, 4 times per week (160 minutes weekly for 6 months), contributes to decreasing erectile problems in men with ED linked to physical inactivity, obesity, hypertension, metabolic syndrome, or cardiovascular disease.

Gerbild H, Larsen CM, Graugaard C, et al. Sex Med, 2018. PMID 29661646

2018 / Meta-analysis of prospective cohort studies

Red meat and poultry consumption were associated with higher hypertension risk, whereas egg consumption was associated with lower risk.

A meta-analysis of 10 prospective cohort studies involving 351,819 participants and 5,000 hypertension cases evaluated associations between meat and egg consumption and hypertension risk. Red meat consumption was positively associated with hypertension risk (multivariable-adjusted RR = 1.22, 95% CI: 1.11-1.35; P < 0.001), with positive associations for both processed (RR = 1.12, 95% CI: 1.02-1.23; P = 0.02) and unprocessed red meat (RR = 1.19, 95% CI: 1.04-1.36; P = 0.01). Poultry intake was also associated with a higher risk of hypertension (RR = 1.15, 95% CI: 1.03-1.28; P = 0.015), whereas egg consumption was associated with a lower risk (RR = 0.79, 95% CI: 0.68-0.91; P = 0.001). The authors noted that the number of included studies was limited.

Shows an association, not proof of cause and effect.

Zhang Y, Zhang DZ J Hum Hypertens, 2018. PMID 29725070

2018 / Systematic review and meta-analysis of controlled trials

The Portfolio dietary pattern significantly reduced LDL-C by ~17% and improved multiple cardiometabolic risk factors in hyperlipidemic participants.

A systematic review and meta-analysis of 7 controlled trial comparisons (439 participants with hyperlipidemia) evaluated the Portfolio dietary pattern on a background NCEP Step II diet versus an NCEP Step II diet alone. The Portfolio diet significantly reduced LDL-C by ~17% (MD, -0.73 mmol/L [95% CI, -0.89 to -0.56 mmol/L]) as well as non-HDL-C, apolipoprotein B, total cholesterol, triglycerides, systolic and diastolic blood pressure, C-reactive protein, and estimated 10-year CHD risk (all p < 0.05). No effect was seen on HDL-C or body weight. Certainty of evidence via GRADE was high for LDL-C and most lipid outcomes, and moderate for other outcomes.

Chiavaroli L, Nishi SK, Khan TA, et al. Prog Cardiovasc Dis, 2018. PMID 29807048

2018 / Systematic review of randomized clinical trials

A systematic review found that beetroot juice supplementation might reduce blood pressure across healthy and hypertensive populations.

A systematic review of randomized clinical trials published from 2008 to 2018 evaluated the effect of beetroot juice intake on arterial blood pressure. Across 11 studies meeting the inclusion criteria, the review demonstrated that beetroot juice supplementation is a cost-effective strategy that might reduce blood pressure in different populations, likely through the nitrate/nitrite/nitric oxide pathway and secondary metabolites in Beta vulgaris. The authors note that several factors related to beetroot juice intake, such as gender and secondary metabolites, warrant further investigation.

Bonilla Ocampo DA, Paipilla AF, Marín E, et al. Biomolecules, 2018. PMID 30400267

2018 / Meta-analysis of observational studies

A vegan diet was associated with a more favourable cardiometabolic profile compared to an omnivorous diet in most countries.

A meta-analysis of 40 observational studies assessed cardiometabolic risk factors in 12,619 vegans and 179,630 omnivores. Compared to controls, vegans had lower body mass index (-1.72 kg/m2, CI -2.30 to -1.16), waist circumference (-2.35 cm, CI -3.93 to -0.76), LDL cholesterol (-0.49 mmol/L, CI -0.62 to -0.36), triglycerides (-0.14 mmol/L, CI -0.24 to -0.05), fasting blood glucose (-0.23 mmol/L, CI -0.35 to -0.10), systolic blood pressure (-2.56 mmHg, CI -4.66 to -0.45), and diastolic blood pressure (-1.33 mmHg, CI -2.67 to -0.02; p<0.0001 for all). In several large studies from Taiwan, however, a vegan diet was not associated with favourable cardio-metabolic risk factors compared to control diets.

Shows an association, not proof of cause and effect.

Benatar JR, Stewart RAH PLoS One, 2018. PMID 30571724

2017 / Meta-analysis of prospective cohort studies

Overweight and obesity are associated with increased risk of developing hypertension

A meta-analysis of 10 prospective cohort studies with 173,828 participants assessed the link between excess weight and hypertension. Compared to normal weight, risk ratios for hypertension were 1.52 (95% CI: 1.37, 1.67) for overweight and 2.17 (95% CI: 1.84, 2.50) for obesity. The excess risk attributable to overweight was 32% (95% CI: 24%, 40%) and to obesity was 47% (95% CI: 40%, 54%).

Shows an association, not proof of cause and effect.

Poorolajal J, Hooshmand E, Bahrami M, et al. J Public Health (Oxf), 2017. PMID 27521927

2017 / Systematic review and meta-analysis of cohort studies

White rice intake was associated with total chronic disease risk in women.

A systematic review identified 19 cohort studies on rice intake, chronic conditions, and mortality. In a meta-analysis of 12 cohorts, comparing extreme categories of rice intake showed a non-significant trend for total chronic diseases (RR 1.11, 95% CI: 0.96 to 1.29), with an association present in women (RR 1.40, 95% CI: 1.13 to 1.73) but not men (RR 0.95, 95% CI: 0.72 to 1.24). Across five cohorts, high intake was not associated with mortality overall (RR 0.97, 95% CI: 0.88 to 1.06), but linked to lower mortality in men (RR 0.87, 95% CI: 0.81 to 0.94).

Shows an association, not proof of cause and effect.

Saneei P, Larijani B, Esmaillzadeh A Public Health Nutr, 2017. PMID 27577106

2017 / Meta-analysis of randomized controlled trials

Blueberry supplementation did not significantly improve blood pressure in clinical trials

A meta-analysis of 6 randomized controlled trials with 204 participants examined blueberry supplementation. The intervention showed no significant effect on systolic blood pressure (mean difference -0.28 mmHg, 95% CI: -1.11 to 0.56) or diastolic blood pressure (mean difference -0.5 mmHg, 95% CI: -1.24 to 0.24). Overall, findings did not demonstrate clinical efficacy for improving blood pressure.

Zhu Y, Sun J, Lu W, et al. J Hum Hypertens, 2017. PMID 27654329

2017 / Meta-analysis of randomized controlled trials

Higher red meat intake did not affect cardiovascular risk factors in trial meta-analysis

A meta-analysis of 24 randomized controlled trials in adults aged 19 and older compared red meat intake of at least 0.5 versus under 0.5 servings daily. Red meat intake did not affect postintervention blood lipids, lipoproteins, or blood pressure (P > 0.05). Across all subjects, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and diastolic blood pressure decreased over time.

NANO counterpoint →

O'Connor LE, Kim JE, Campbell WW Am J Clin Nutr, 2017. PMID 27881394

2017 / Meta-analysis of randomized controlled trials

Oral potassium supplementation modestly reduced blood pressure in adults with primary hypertension

A meta-analysis evaluated 23 randomized placebo-controlled trials encompassing 1,213 individuals with primary hypertension treated for at least 4 weeks. Potassium supplementation reduced systolic blood pressure by 4.25 mmHg (95% CI: -5.96 to -2.53) and diastolic blood pressure by 2.53 mmHg (95% CI: -4.05 to -1.02). The authors reported no significant adverse events associated with the intervention.

Poorolajal J, Zeraati F, Soltanian AR, et al. PLoS One, 2017. PMID 28419159

2017 / Systematic review and meta-analysis of trials

Chronic ingestion of licorice products containing glycyrrhizic acid significantly increased blood pressure and reduced plasma potassium in a meta-analysis.

A systematic review and meta-analysis of 18 trials (n=337) evaluated the effects of chronic ingestion of products containing at least 100 mg of glycyrrhizic acid daily. Licorice ingestion significantly increased mean systolic blood pressure by 5.45 mm Hg (95% CI 3.51-7.39) and diastolic blood pressure by 3.19 mm Hg (95% CI 0.10-6.29). Significant decreases occurred in plasma potassium (-0.33 mmol l-1, 95% CI -0.42 to 0.23), plasma renin activity (-0.82 ng ml-1 per hour, 95% CI -1.27 to -0.37), and plasma aldosterone (-173.24 pmol l-1, 95% CI -231.65 to -114.83). Daily dose correlated significantly with systolic (r2=0.55) and diastolic blood pressure (r2=0.65).

Penninkilampi R, Eslick EM, Eslick GD J Hum Hypertens, 2017. PMID 28660884

2017 / Umbrella review of meta-analyses of observational studies and RCTs

Coffee consumption was linked to a lower risk of multiple cancers, cardiovascular disease, mortality, Parkinson's disease, and type-2 diabetes.

An umbrella review evaluated evidence from meta-analyses of observational studies and randomized controlled trials on coffee and caffeine consumption. Across 112 observational meta-analyses covering 59 unique outcomes, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers, cardiovascular disease and mortality, Parkinson's disease, and type-2 diabetes. Across 20 observational meta-analyses covering 14 unique outcomes, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes, but an increased risk of pregnancy loss. Among 9 RCT meta-analyses examining 12 acute outcomes, coffee was associated with elevated serum lipids (affected by significant heterogeneity) and caffeine with elevated blood pressure.

Shows an association, not proof of cause and effect.

Grosso G, Godos J, Galvano F, et al. Annu Rev Nutr, 2017. PMID 28826374

2016 / Systematic review and meta-analysis of randomized controlled trials

Flaxseed supplements reduce systolic and diastolic blood pressure in randomized controlled trials

A meta-analysis of 15 randomized trials comprising 1,302 subjects found that flaxseed products significantly lowered systolic blood pressure (WMD: -2.85 mmHg, 95% CI: -5.37 to -0.33, p = 0.027) and diastolic blood pressure (WMD: -2.39 mmHg, 95% CI: -3.78 to -0.99, p = 0.001). Systolic drops were significant with powder but not oil or lignans, whereas diastolic declines occurred with both powder and oil forms.

Ursoniu S, Sahebkar A, Andrica F, et al. Clin Nutr, 2016. PMID 26071633

2016 / Updated meta-analysis and review of randomized controlled trials

Garlic preparations reduced systolic and diastolic blood pressure, with larger reductions seen in hypertensive individuals.

Researchers updated a meta-analysis of randomized controlled trials evaluating the effect of garlic preparations on blood pressure and reviewed its effects on cholesterol and immunity. In 20 trials with 970 participants, garlic decreased systolic blood pressure by a mean ± SE of 5.1 ± 2.2 mm Hg (P < 0.001) and diastolic blood pressure by 2.5 ± 1.6 mm Hg (P < 0.002) compared with placebo. In trials of hypertensive subjects, reductions were larger: 8.7 ± 2.2 mm Hg for SBP (P < 0.001; n = 10) and 6.1 ± 1.3 mm Hg for DBP (P < 0.001; n = 6). A previously published meta-analysis cited in the review noted a 10% reduction in total and LDL cholesterol when taken for >2 months by individuals with slightly elevated levels, and clinical trials showed reductions in upper respiratory infections.

Ried K J Nutr, 2016. PMID 26764326

2016 / Systematic review and meta-analysis of randomized controlled trials

Weight loss diets reduced blood pressure and body weight in adults with hypertension.

In a systematic review of eight randomized trials with 2,100 adults with primary hypertension, dietary weight loss interventions lasting 6 to 36 months lowered systolic blood pressure by -4.5 mm Hg (95% CI -7.2 to -1.8 mm Hg) and diastolic blood pressure by -3.2 mm Hg (95% CI -4.8 to -1.5 mm Hg). Participants on weight-reducing diets also lost weight compared to controls (mean difference -4.0 kg, 95% CI -4.8 to -3.2 kg). Effects on mortality and morbidity remain unknown.

Semlitsch T, Jeitler K, Berghold A, et al. Cochrane Database Syst Rev, 2016. PMID 26934541